Related Experiment Video
Updated: Jun 22, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Synergistic effect of diosmin and interferon-alpha on metastatic pulmonary melanoma
Nuria Alvarez1, Vicente Vicente, Cristina Martínez
1University of Murcia Institute of Research into Aging, Department of Pathology, Faculty of Medicine, University of Murcia, Murcia, Spain. nalvarez@um.es
Abstract:
Melanoma is the most important skin cancer in terms of mortality, besides developing metastasis in about a third of the patients. Interferon-alpha (IFN-alpha), a highly toxic cytokine, tends to be one of the most important treatments for melanoma. Much effort is being directed at obtaining less-toxic antitumoral compounds, particularly natural compounds such as flavonoids. Our aim was to study the combined treatment of metastatic lung melanoma with IFN-alpha and diosmin in a murine model. In this article, we report the effect of a combined treatment of IFN-alpha and the flavonoid, diosmin, on a murine model of metastatic B16F10 melanoma, assessed both macroscopically (counting subpleural nodules) and microscopically by image analysis (calculating three indices). IFN-alpha showed a dose-dependent anti-invasive and antiproliferative activity in our study, while diosmin showed an anti-invasive activity similar to the lower dose of IFN-alpha used. However, the most relevant result was the synergistic antiproliferative effect shown by the combination of the flavonoid and the lowest dose of IFN-alpha, which was similar to that produced by the highest dose of the cytokine alone.
Insights
Combining the flavonoid diosmin with interferon-alpha (IFN-alpha) showed synergistic effects against metastatic melanoma in mice. This combination therapy offers a promising, less toxic approach to treating advanced skin cancer.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Research
Background:
- Melanoma is a significant cause of cancer mortality, often metastasizing.
- Interferon-alpha (IFN-alpha) is a toxic but established treatment for melanoma.
- There is a need for less toxic melanoma therapies, including natural compounds like flavonoids.
Purpose of the Study:
- To investigate the combined therapeutic effects of IFN-alpha and the flavonoid diosmin.
- To evaluate this combination therapy in a murine model of metastatic B16F10 melanoma.
- To assess both macroscopic and microscopic outcomes of the combined treatment.
Main Methods:
- Utilized a murine model of metastatic B16F10 melanoma.
- Administered combined treatment with IFN-alpha and diosmin.
- Assessed treatment efficacy macroscopically by counting subpleural nodules.
- Evaluated outcomes microscopically using image analysis to calculate specific indices.
Main Results:
- IFN-alpha demonstrated dose-dependent anti-invasive and antiproliferative activity.
- Diosmin exhibited anti-invasive activity comparable to a low dose of IFN-alpha.
- A synergistic antiproliferative effect was observed when combining diosmin with the lowest dose of IFN-alpha, matching the efficacy of the highest IFN-alpha dose alone.
Conclusions:
- The combination of diosmin and IFN-alpha exhibits synergistic antiproliferative effects in metastatic melanoma.
- This combination therapy may offer a less toxic and effective treatment strategy for advanced melanoma.
- Flavonoids like diosmin hold potential as adjuncts in melanoma treatment regimens.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Viral Protein Synthesis

